Philipp Dahm, MD

Southeastern Section

Dr. Dahm currently holds the position of Associate Professor of Urology and Director of Clinical Research in the Department of Urology at the University of Florida. He earned his medical degree from the University of Heidelberg and completed his urology residency at Duke University Medical Center, where he subsequently completed an Urology Care Foundation Scholarship and a Master of Health Sciences in Clinical Research. Dr. Dahm specializes in genitourinary oncology and maintains a dedicated interest in outcomes research, research methodology and evidence-based decision making.

Alexander Gomelsky, MD

Southeastern Section

Dr. Gomelsky is Assistant Professor of Urology and Director of the Section of Female Urology, Neurourology and Pelvic Reconstructive Surgery at the Louisiana State Health Sciences Center in Shreveport, LA. He obtained his medical degree at the University of Maryland, followed by a urology residency at Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM) in Akron, OH, and a fellowship in Female Urology and Pelvic Floor Reconstruction at Vanderbilt University Medical Center. He has served on the AUA Practice Management Committee and the AUA Urology Core Curriculum Section for Urodynamics. His academic interests include outcomes research in incontinence, prolapse surgery and neurogenic bladder conditions.

Jeffrey M. Holzbeierlein, MD

South Central Section

Dr. Holzbeierlein is an Associate Professor of Urology at Kansas University Medical Center in Kansas City, KS, where he holds the John W. Weigel Endowed Chair. He began his medical career at Vanderbilt University where he earned his Bachelor of Science in chemistry. He completed medical school at the University of Oklahoma and went back to Vanderbilt to complete his residency. He then ventured to New York City to complete his fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Holzbeierlein's clinical practice is focused on urologic oncology and his passion lies in the pursuit of the promotion of urology as a specialty.

Dr. Holzbeierlein has authored several editorials, presentations and publications in peer-reviewed journals. He serves as the assistant editor for The Journal of Urology® and an Executive Board Member of the Society for Urologic Oncology. He is also a member of the American Urological Association (AUA), where he also serves on the Young Urologist's Committee and is the past chair of the Young Urologic Oncologists Section. Dr. Holzbeierlein has won many awards, including the Department of Defense New Investigator Award, and was a co-investigator of an R01 Research Award.

Jean V. Joseph, MD

Northeastern Section

Dr. Joseph is an Associate Professor of Urology and Oncology at the University of Rochester Medical Center. He is Head of the Section of Urologic Laparoscopy and Robotic Surgery, and Director of the Fellowship in Endourology, Laparoscopy and Robotic Surgery. He received his Bachelor of Science in biology from Boston University and his medical degree from the University of Rochester School of Medicine. Dr. Joseph also earned his Master of Business Administration from the Rochester Institute of Technology, College of Business. He completed his residency in urology at the University of Rochester School of Medicine and received post-graduate training at the Institute of Urology, University College, London.

His clinical and research interests have focused on improving outcomes in patients treated surgically for prostate cancer using laparoscopic and robotic technology. Dr. Joseph has authored numerous articles and book chapters on minimally invasive surgery and also co-edited a book titled, Minimally Invasive Surgery: Looking through the Key Hole. He is an active member of the AUA, the Endourological Society, the National Medical Association (NMA) and the Medical Society of the State of New York.

Ashish Madhav Kamat, MD

South Central Section

Dr. Kamat is an Assistant Professor and Director of the Urologic Oncology Fellowship Program at M. D. Anderson Cancer Center in Houston, TX. His clinical practice is focused entirely on urologic oncology, including minimally invasive therapies, and his research is focused on bladder cancer, especially novel targets for therapy.

Dr. Kamat has authored editorials and more than 65 publications in peer-reviewed journals, serves on the editorial board of Expert Reviews in Anticancer Therapy and is listed in Who's Who in Medicine. His translational research is funded by peer-reviewed awards from the National Cancer Institute (NCI) and he is a co-project Principal Investigator on the MD Anderson Cancer Center GU (Bladder) Specialized Program of Research Excellence (SPORE) study. Dr. Kamat is an active member of the AUA, the Society of Urologic Oncology and cancer support groups, such as the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN).

Badrinath R. Konety, MD

Western Section

Dr. Konety is Associate Professor and Vice-Chair of the Department of Urology at the University of California, San Francisco and Chief of the Urology Section at the VA Medical Center, San Francisco. He completed his residency training and American Foundation for Urologic Disease fellowship at the University of Pittsburgh and a clinical fellowship in Urologic Oncology at the Memorial Sloan-Kettering Cancer Center in New York City.

Dr. Konety has written more than 85 peer-reviewed publications in a variety of areas pertaining to genitourinary cancers. He has received grant support from numerous organizations, including the National Kidney Foundation, National Institutes of Health (NIH), American Foundation for Urologic Disease (AFUD, now the American Urological Association Foundation), American Geriatrics Society (AGS) and the American Cancer Society (ACS). Dr. Konety's current research areas include the study of the diagnostic and prognostic utility of diagnostic markers for bladder cancer outcomes and quality of life in patients with bladder and prostate cancer; prostate and urologic cancer therapy in the elderly population to develop models of outcome risk prediction; and clinical trials of novel therapies,including gene therapy, for prostate and bladder cancer. He has previously been an AUA-European Association of Urology (EAU) Exchange Scholar.

Ravi Munver, MD

New York Section

Dr. Munver is Associate Professor and Vice Chairman of Urology at Touro University College of Medicine and Hackensack University Medical Center. He is Chief of Minimally Invasive and Robotic Urologic Surgery and Director of a minimally invasive urology fellowship program accredited by the Endourological Society. He received his undergraduate and medical education at Cornell University. He completed residency training at Duke University Medical Center and a fellowship in endourology, laparoscopy and robotic surgery at New York-Presbyterian Hospital—Cornell Medical Center. He has authored more than 200 scientific manuscripts, articles, book chapters and abstracts, and maintains active membership in the Society of Laparoendoscopic Surgeons, the Physician Leadership Academy and the AUA, where he won first prize in the Montague L. Boyd Essay Competition at the AUA Annual Meeting in 2000.

J. Kellogg Parsons, MD

Western Section

Dr. Parsons is an Assistant Professor of Surgery at the University of California, San Diego and a Staff Investigator at the Moores UCSD Comprehensive Cancer Center. He received his Bachelor of Arts degree from Stanford University, his medical degree from the University of Pennsylvania and his Master of Health Science from The Johns Hopkins Bloomberg School of Public Health. He completed his residency training and fellowship in Urologic Oncology at The Johns Hopkins School of Medicine. The author of more than 60 articles and book chapters, he has co-edited three textbooks. His research focuses on the epidemiology and prevention of urological cancers and benign prostatic hyperplasia (BPH). He is the recipient of a Department of Defense Physician Research Training Award to study diet and prostate cancer.

John L. Phillips, MD

New York Section

Dr. Phillips is Chief, Genito-Urinary Oncology, and Robotic and Minimally Invasive Surgery at Westchester County Medical Center and Metropolitan Hospital in New York. He has published and lectured widely on genomics and molecular cytogenetics in bladder, renal and prostate cancers. As Assistant Professor at New York Medical College, his research deals with activating mutations of tyrosine kinases in bladder cancer, PSA kinetics, clinical outcomes research in robotic surgery and the socio-economic history of Medicare development and reform.

Richard A. Santucci, MD

North Central Section

Dr. Santucci is the Specialist-in-Chief, Urology, at the nine-hospital Detroit Medical Center, and the Director of Detroit's Center for Urologic Reconstruction. He has published and lectured widely in the subspecialty of trauma and reconstructive urology, both here and abroad. Dr. Santucci is a Clinical Professor at the Michigan State College of Osteopathic Medicine, and is the Residency Site Director for Michigan State University's newest urology residency program housed at the Detroit Medical Center. Dr. Santucci remains committed to improving the quality of trauma and reconstructive urology care around Michigan, the nation and the world.

D. Robert Siemens, MD

Northeastern Section

Dr. Siemens graduated from medical school and subsequently completed his urology residency at Queen's University. He received a McLaughlin Fellowship to study oncology at the University of Iowa. Since 2006, he has held an appointment as Associate Professor in the Department of Urology, with cross-appointments to the Departments of Oncology and Anatomy and Cell Biology, where his research includes investigation into the phenotypic changes of cancer in a hypoxic environment.

Dr. Siemens has published more than 55 papers and abstracts and participates in numerous national and international meetings. He has received research grants and scholarships from organizations, such as the AUA, Canadian Cancer Society (CCS) and the Canadian Urologic Association (CUA). Over the last five years, Dr. Siemens has sat on the Urology Examination Board and Test Committee at the Royal College of Physicians and Surgeons in Canada. He was also the recipient of the 2005 Canadian Medical Association Leadership Award.

Chandru P. Sundaram, MD

North Central Section

Dr. Chandru Sundaram has been Associate Professor and Director of Minimally Invasive Urology at Indiana University School of Medicine since 2002, when he moved from Washington University in St. Louis where he served as Assistant Professor. His area of interest includes laparoscopic and robot assisted surgery of the kidney, prostate and adrenal gland. He has authored or co-authored over 75 peer-reviewed publications. He directs a fellowship in Minimally Invasive Surgery and is the urology residency program director at Indiana University. He is on the Editorial Board of the Journal of Endourology and is a member of the AUA's Laparoscopy & Robotic Surgery Committee.

John Arthur Taylor III, MD

New England Section

Dr. Taylor is an Assistant Professor of Surgery in the Division of Urology at the University of Connecticut Health Center and Chairman of the Cancer Committee in the Neag Comprehensive Cancer Center. He received his Bachelor of Science in biology from Lafayette College and his medical degree from Columbia University College of Physicians and Surgeons. He completed his two-year surgical and four-year urological training at Columbia University's Presbyterian Medical Center, after which he served on active military duty at Walter Reed Army Medical Center for three years.

Dr. Taylor has authored and contributed to many publications. He is an active investigator for the pathogenesis of high-grade bladder cancer and recipient of many awards, including AUA?s Post-Residency Research Award. Additionally, he has received a Geriatrics Education for Specialty Residents educational grant. His work is currently supported by the National Institutes of Health (NIH) and American Cancer Society (ACS).

Edouard J. Trabulsi, MD

Mid-Atlantic Section

Dr. Trabulsi is an Assistant Professor at the Kimmel Cancer Center in Philadelphia, PA, as well as Assistant Professor in Urology at Thomas Jefferson University. He received his Bachelor of Science in biochemistry from the University of Rochester and completed his medical degree at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed his urology residency, surgery residency and internship in surgery at Thomas Jefferson University. He also completed fellowships in urologic oncology and minimally invasive urologic oncology at the Memorial Sloan-Kettering Cancer Center in New York City.

Dr. Trabulsi is the Co-Director of the Genitourinary (GU) Oncology Multidisciplinary Cancer Clinic at the Kimmel Cancer Center, the Jefferson Prostate Diagnostic Center and well as the CR Bard/Bagley Fellowship in Laparoscopy and Endourology. He is a member of the AUA?s Urologic Ultrasound Faculty Committee. He has published numerous scientific papers, abstracts and book chapters on urologic oncology and prostate ultrasonography. He is a member of the AUA, the American Society of Clinical Oncology (ASCO) and the Society of Urologic Oncology (SUO).

David S. Wang, MD

New England Section

Dr. Wang currently serves as an Assistant Professor of Urology at Boston University School of Medicine as well as Staff Urologist at Veterans Affairs Boston Healthcare System. After graduating from Yale University School of Medicine, Dr. Wang was an intern and resident in general surgery at Massachusetts General Hospital. He then completed his residency in urology at the Lahey Clinic Medical Center. Following residency, Dr. Wang completed a fellowship in minimally invasive urologic surgery at the University of Iowa Hospitals and Clinics.

Dr. Wang's clinical interests involve all aspects of minimally invasive urologic surgery. He is an expert in laparoscopic and robotic surgery of the urinary tract, and his expertise also extends to endoscopic management of urinary tract conditions. He was a member of the surgical team that performed the first robotic prostatectomy in Massachusetts. Dr. Wang has authored and contributed to numerous publications and textbook chapters. He is an active member of the AUA, the Endourological Society and several other organizations and committees.

Stanley Zaslau, MD

Mid-Atlantic Section

Dr. Stanley Zaslau is an Associate Professor and serves as the Residency Program Director of the Urology Residency Training Program at West Virginia University. Dr. Zaslau received his Bachelor of Arts degree from Boston University. He received his medical degree from Hahnemann University School of Medicine. He did his urology residency at Mount Sinai Medical Center, New York City before completing his Physician Executive Master of Business Administration at the University of Tennessee. He is certified by the American Board of Urology (ABU), the American College of Physician Executives (ACPE) and the American College of Health Care Executives (ACHCE).